CNS Pharmaceuticals (CNSP) Other Operating Expenses (2020)

CNS Pharmaceuticals' (CNSP) quarterly Other Operating Expenses came in at $4.7 million in Q4 2020.

CNS Pharmaceuticals (CNSP) Other Operating Expenses (2020) Analysis & Trends

CNS Pharmaceuticals (CNSP) has 1 years of Other Operating Expenses data on file, last reported at $4.7 million in Q4 2020.

Quarterly Other Operating Expenses changed N/A year-over-year to $4.7 million in Q4 2020, while the trailing twelve-month figure through Sep 2021 was $4.7 million (changed N/A YoY) and the FY2020 annual result came in at $4.7 million, changed N/A from the prior year.
Other Operating Expenses was little changed at $4.7 million in Q4 2020.
In the past five years, Other Operating Expenses ranged from a high of $4.7 million in Q4 2020 to a low of $4.7 million in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	CNS Pharmaceuticals	2.65 Mn	-4.55 Mn	-

Download Data

Date	Value
Dec 31, 2020	4.66 Mn